Cite
HARVARD Citation
Chen, W. et al. (2020). Efficacy and safety of low‐dose apatinib in ovarian cancer patients with platinum‐resistance or platinum‐refractoriness: A single‐center retrospective study. Cancer medicine. pp. 5899-5907. [Online].